| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |